New Jersey A919 requires NJ FamilyCare providers to inform and obtain consent from parents or guardians of children prescribed antipsychotic drugs.

New Jersey A919 mandates that health care providers enrolled in NJ FamilyCare, New Jersey's health insurance program for low-income residents, must provide specific information to parents or guardians before prescribing antipsychotic drugs to children. This includes sharing the FDA-approved Medication Guide, details on evidence-based alternatives, and information on FDA's Adverse Event Reporting System. The provider must also obtain a signed consent form from the parent or guardian, ensuring they understand the drug's risks, alternatives, and reporting tools.

New Jersey A919 requires NJ FamilyCare providers to inform and obtain consent from parents or guardians of children prescribed antipsychotic drugs.

New Jersey A919 mandates that health care providers enrolled in NJ FamilyCare, New Jersey's health insurance program for low-income residents, must provide specific information to parents or guardians before prescribing antipsychotic drugs to children. This includes sharing the FDA-approved Medication Guide, details on evidence-based alternatives, and information on FDA's Adverse Event Reporting System. The provider must also obtain a signed consent form from the parent or guardian, ensuring they understand the drug's risks, alternatives, and reporting tools.